Finance

Lists
603590:SHA
Beijing Konruns Pharmaceutical Co Ltd
27,30 CN¥
-1,30%
(-0,36) 1D
16 қаз., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603590...
Open
28,02 CN¥
High
28,84 CN¥
Low
27,10 CN¥
Mkt. cap
4,40 млрд
Avg. vol.
2,36 млн
Volume
3,32 млн
Dividend
1,28%
Quarterly dividend
0,09 CN¥
Ex-dividend date
2026 ж. 08 шіл.
P/E ratio
25,47
52-wk high
54,86 CN¥
52-wk low
27,10 CN¥
EPS
1,07 CN¥
Shares outstanding
160,00 млн
No. of employees
793
Open
28,02 CN¥
High
28,84 CN¥
Low
27,10 CN¥
Mkt. cap
4,40 млрд
Avg. vol.
2,36 млн
Volume
3,32 млн
Dividend
1,28%
Quarterly dividend
0,09 CN¥
Ex-dividend date
2026 ж. 08 шіл.
P/E ratio
25,47
52-wk high
54,86 CN¥
52-wk low
27,10 CN¥
EPS
1,07 CN¥
Shares outstanding
160,00 млн
No. of employees
793
News stories
From web sources and news partners
About Beijing Konruns Pharmaceutical Co Ltd
CEO-
Employees793
Founded2003 ж. 03 қыр.
Headquarters-
SectorPharmaceutical industry
Websitekonruns.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
231,35 млн
222,90 млн
214,87 млн
247,93 млн
Cost of goods sold
22,91 млн
24,09 млн
21,90 млн
25,26 млн
Cost of revenue
22,91 млн
24,09 млн
21,90 млн
25,26 млн
Research and development expenses
12,30 млн
19,06 млн
13,34 млн
26,66 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
154,66 млн
141,77 млн
116,52 млн
141,17 млн
Operating expense
166,20 млн
167,04 млн
133,22 млн
168,99 млн
Total operating expenses
189,12 млн
191,13 млн
155,12 млн
194,26 млн
Operating income
42,23 млн
31,77 млн
59,75 млн
53,67 млн
Other non operating income
-14,51 млн
12,12 млн
-636,15 м.
584,04 м.
EBT including unusual items
38,44 млн
41,48 млн
58,70 млн
62,24 млн
EBT excluding unusual items
28,50 млн
47,88 млн
60,43 млн
61,01 млн
Income tax expense
475,46 м.
6,35 млн
10,19 млн
10,18 млн
Effective tax rate
1,24%
15,32%
17,36%
16,36%
Other operating expenses
113,66 м.
5,54 млн
1,21 млн
2,64 млн
Net income
36,83 млн
38,09 млн
47,21 млн
48,51 млн
Net profit margin
15,92%
17,09%
21,97%
19,57%
Earnings per share
-
-
-
-
Interest and investment income
1,19 млн
9,96 млн
3,52 млн
10,46 млн
Interest expense
-2,08 млн
-2,13 млн
-2,20 млн
-2,39 млн
Net interest expenses
-889,52 м.
7,84 млн
1,32 млн
8,07 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
49,22 млн
39,15 млн
67,12 млн
62,47 млн
Gain or loss from assets sale
130,67 м.
553,62 м.
-
-
AI content may include mistakes. Learn more
Google қолданбалары